Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?
Yahoo! Finance
After declining 19% in 2022, the S&P 500 has risen about 4% this year as investors grew accustomed to inflation, rising interest rates, and other macro headwinds. Let's see if the four worst-performing S&P 500 components so far in 2023 -- Lumen Technologies (NYSE: LUMN), Moderna (NASDAQ: MRNA), Baxter International (NYSE: BAX) and Pfizer (NYSE: PFE) -- are actually contrarian buys.
Continue Reading